4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Follow Us : Follow On Facebook Follow On Twitter Follow On Youtube
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
NON - HODGKIN'S LYMPHOMA (NHL)
Non Hodgkin's Lymphoma (NHL)
Dr Ira Shah
M.D, DCH(Gold Medalist), FCPS, DNB
Edited by Dr. Bharat R Agarwal
Consultant Pediatric Hematologist and Oncologist.


Q: What is cellular classification and why is it important?

A: NHL is classified as low, intermediate or high grade on basis of their clinical aggressiveness. Lymphomas in children are usually high grade and are classified into 4 categories.
  • Burkitt's and Burkitt's like lymphoma/small non-cleaved B cell lymphoma.

  • Lymphoblastic lymphoma.

  • Diffuse large cell lymphoma.

  • Anaplastic large cell lymphoma.

Histopathological classification of NHL in children (Table 1)

Subtype
Immunophenotype
Clinical presentation
Percentage of cases
Small non-cleaved cell

(Burkitt's)
Mature B

Cell.
Intra-abdominal

(sporadic)

jaw (endemic)
34%
Lymphoblastic

Lymphoma
T cell

Pre - B cell
Mediastinal or Head & neck
29%
Large cell lymphoma
B cell

T cell
Variable
27%
Anaplastic large cell
T cell

Null
Variable
10%


By histological classification of NHL, it helps to determine the prognosis and therapy. The prognosis is excellent in children with stage I or II NHL of any histologic subtype who receive therapy. However, for lymphoblastic NHL, longer therapy may be required. In patients with advanced disease, Burkitt's lymphoma can be adequately treated whereas patients with lymphoblastic NHL have to be treated as ALL.

Q: How is NHL treated?

A: Multiagent chemotherapy is the treatment of choice. Surgery is very limited and is usually for diagnostic purpose. Irradiation to primary sites is usually restricted to emergency situations.

Treatment for lymphoblastic lymphoma :

Stage I & II :-
  • Vincristine, Doxorubicin, cyclophosphamide, prednisone, mercaptopurine, methotrexate.

  • CHIP plus methotrexate - cyclophosphamide, doxorubicin, vincristine, prednisolone.

  • COMP: cyclophosphamide, vincristine, methotrexate, prednisolone.

CNS prophylaxis should be given to all patients with primary tumors of the head and neck. Intrathecal methotrexate is highly effective.

Stage III :-
  • LSA2L2 regime + 10 courses of methotrexate.

  • CHOP + methotrexate.

  • BFM - NHL 90.

Stage IV :-
  • BFM - NHL 90.

  • LSA2L2 + methotrexate.

*CNS prophylaxis should be given to all patients with disseminated lymphoblastic lymphoma even if CNS disease is not detectable at presentation. Here, radiation for CNS prophylaxis should be considered.

Treatment of Small Non-cleaved cell lymphoma :

Stage I & II :-
  • COMP

  • CHOP

  • CHOP + Methotrexate.

  • NHL - BFM 90.

  • French LMB - 89 - High dose cyclophosphamide,high dose Methotrexate/Leucovorin,cytarabine,Vincristine,Prednisone,Doxorubicin.
Stage III :-
  • French LMB - 89

  • NHL - BFM - 90
Other therapies are under evaluation

Stage IV :-
  • French LMB - 89

  • NHL - BFM - 90
Other therapies are under evaluation

Treatment of Large cell lymphoma :

Stage I & II :-
  • COMP

  • CHOP
Treatment consists of a short course of combination chemotherapy with combined CNS prophylaxis for patients with head and neck primaries.

Stage III & IV :-
  • APO: Doxorubicin, Prednisolone, Vincristine, Methotrexate

  • ACOP+

  • CHOP

  • NHL - BFM 90

 
 
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us